(Q37524489)

20 August 2017

1 reference

title

Lithium specificity in bipolar illness: a classic agent for the classic disorder (English)

1 reference

20 August 2017

0 references

3

Gin S Malhi

1 reference

20 August 2017

Samuel Gershon

1

1 reference

20 August 2017

K N Roy Chengappa

series ordinal

2

1 reference

20 August 2017

publication date

1 June 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

11 Suppl 2

1 reference

20 August 2017

page(s)

34-44

1 reference

Characteristics and significance of untreated major depressive disorder

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2009.00709.X

Loss of Antidepressant Efficacy During Maintenance Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2009.00709.X

Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2009.00709.X

A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizo-affectives. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2009.00709.X

Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2009.00709.X

A double-blind comparison of valproate and lithium in the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2009.00709.X

Depression during mania. Treatment response to lithium or divalproex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2009.00709.X

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2009.00709.X

Lithium Response in Unipolar Versus Bipolar Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2009.00709.X

Lithium in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2009.00709.X

Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2009.00709.X

Are There Two Types of Unipolar Depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2009.00709.X

An assessment of clinically useful measures of the consequences of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2009.00709.X

Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2009.00709.X

Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2009.00709.X

Factors associated with treatment success in lithium carbonate prophylaxis. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2009.00709.X

10.1111/J.1399-5618.2009.00709.X

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference